Now online @LancetRH_Europe & pubmed: Our review on: Atrial fibrillation: epidemiology, screening and digital health
Atrial fibrillation: epidemiology, screening and digital health.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Feb 2024 – Jul 2025Where it's discussed
-
X / Twitter19 posts
-
YouTube2 videos
AI synopsis
What people are saying
The overall tone shows strong agreement, with posts highlighting the dramatic increase in AF cases and the role of digital health tools, such as mobile devices, as potential game changers in early detection. For example, posts describing the prevalence rise and emphasizing the need for innovative screening reflect high interest and impact, using words like 'important' and 'highlighting' to stress relevance and urgency.
The discussions uniformly emphasize the importance of the article's focus on AF epidemiology, screening, and digital health, showing strong support for its conclusions.
Participants demonstrate high interest by actively sharing details of the prevalence increase and related screening methods, highlighting engagement with the subject matter.
Most posts reference key concepts like digital health tools and epidemiology, indicating substantial engagement, though some are more promotional or brief.
The discussions underscore the significance of digital health innovations and the rising prevalence of AF, reflecting a recognition of the article's potential influence on clinical practices and future research.
Abstract in brief
- Atrial fibrillation (AF) is very common, especially after age 45, with the global number of cases increasing from 335 million in 2010 to 59 million in 2019, highlighting the importance of early detection and treatment to reduce complications.
- International guidelines recommend screening for AF, using digital health tools like mobile health (mHealth) devices, which can help identify AF early and facilitate management, but more high-quality research is needed to implement these approaches broadly.
- This review discusses current epidemiology, screening methods, and how digital health solutions, particularly mHealth, can improve integrated AF care, emphasizing the need for further evidence to support widespread adoption of digital interventions for chronic disease management.]
Top posts
Most liked on X and Bluesky#ACNAPTopicOfTheMonth The global prevalence of #AF increased from 33.5 million to 59 million individuals Learn more about #epidemiology, #screening and #digitalhealth in relation to #AF here: https://t.co/PhFJKDnrSv https://t.co/EToYtcxQVw
Atrial fibrillation: epidemiology, screening and digital health #Afib #EPeeps @LHCHFT @LJMU_Health @LivHPartners @affirmo_eu https://t.co/vcxkIqqAWO https://t.co/kcw4gu2xQG
Unser Lesetipp für heute... ❤️https://t.co/BkBg0RtKuP Viel Spaß!
RT @ACNAPPresident: #ACNAPTopicOfTheMonth The global prevalence of #AF increased from 33.5 million to 59 million individuals Learn more a…
RT @ACNAPPresident: #ACNAPTopicOfTheMonth The global prevalence of #AF increased from 33.5 million to 59 million individuals Learn more a…
All mentions
Exploring PPG: A Key Technology for Heart Rhythm Monitoring
This lecture delves into Photoplethysmography (PPG), a noninvasive technology used in health monitoring devices. By measuring blood flow through light, PPG allows for the detection of irregular heart rhythms, including…
Understanding PPG: Its Role in Wearables and Heart Health
Photoplethysmography (PPG) is a powerful noninvasive technique that uses light to monitor various physiological parameters. This video delves into how PPG measures irregular heart rhythms, particularly in wearables like…
RT @ACNAPPresident: #ACNAPTopicOfTheMonth The global prevalence of #AF increased from 33.5 million to 59 million individuals Learn more a…
RT @ACNAPPresident: #ACNAPTopicOfTheMonth The global prevalence of #AF increased from 33.5 million to 59 million individuals Learn more a…
RT @ACNAPPresident: #ACNAPTopicOfTheMonth The global prevalence of #AF increased from 33.5 million to 59 million individuals Learn more a…
RT @ACNAPPresident: #ACNAPTopicOfTheMonth The global prevalence of #AF increased from 33.5 million to 59 million individuals Learn more a…
RT @ACNAPPresident: #ACNAPTopicOfTheMonth The global prevalence of #AF increased from 33.5 million to 59 million individuals Learn more a…
RT @ACNAPPresident: #ACNAPTopicOfTheMonth The global prevalence of #AF increased from 33.5 million to 59 million individuals Learn more a…
RT @ACNAPPresident: #ACNAPTopicOfTheMonth The global prevalence of #AF increased from 33.5 million to 59 million individuals Learn more a…
RT @ACNAPPresident: #ACNAPTopicOfTheMonth The global prevalence of #AF increased from 33.5 million to 59 million individuals Learn more a…
#ACNAPTopicOfTheMonth The global prevalence of #AF increased from 33.5 million to 59 million individuals Learn more about #epidemiology, #screening and #digitalhealth in relation to #AF here: https://t.co/PhFJKDnrSv https://t.co/EToYtcxQVw
Unser Lesetipp für heute... ❤️https://t.co/BkBg0RtKuP Viel Spaß!
RT @Dominik_Linz: Now online @LancetRH_Europe & pubmed: Our review on: Atrial fibrillation: epidemiology, screening and digital health
RT @Dominik_Linz: Now online @LancetRH_Europe & pubmed: Our review on: Atrial fibrillation: epidemiology, screening and digital health
RT @Dominik_Linz: Now online @LancetRH_Europe & pubmed: Our review on: Atrial fibrillation: epidemiology, screening and digital health
Now online @LancetRH_Europe & pubmed: Our review on: Atrial fibrillation: epidemiology, screening and digital health
【文献メモ】 Atrial fibrillation: epidemiology, screening and digital health https://t.co/pU5SkCqymx
RT @LiverpoolCCS: Atrial fibrillation: epidemiology, screening and digital health #Afib #EPeeps @LHCHFT @LJMU_Health @LivHPartners @affirmo…
RT @LiverpoolCCS: Atrial fibrillation: epidemiology, screening and digital health #Afib #EPeeps @LHCHFT @LJMU_Health @LivHPartners @affirmo…
RT @LiverpoolCCS: Atrial fibrillation: epidemiology, screening and digital health #Afib #EPeeps @LHCHFT @LJMU_Health @LivHPartners @affirmo…
Atrial fibrillation: epidemiology, screening and digital health #Afib #EPeeps @LHCHFT @LJMU_Health @LivHPartners @affirmo_eu https://t.co/vcxkIqqAWO https://t.co/kcw4gu2xQG